2015
DOI: 10.1002/elsc.201400255
|View full text |Cite
|
Sign up to set email alerts
|

Domain antibody downstream process optimization: High‐throughput strategy and analytical methods

Abstract: Application of scale-down high-throughput screening has become integral for process development of antibody therapeutic products. In this work, methods are described for using high-throughput techniques to develop a multicolumn chromatography purification protocol for a small domain antibody with very limited material (<200 mg). Screenings utilized resin slurry plates to explore and narrow potential operating space, and miniature columns were used to either confirm operating spaces or further explore impurity … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
6
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 18 publications
1
6
0
Order By: Relevance
“…However, human involvement was still needed in most steps, for example, in designing the experimental plan, in programming and initiating the liquid handling unit, in data treatment obtained from the plate reader, as well as in modification the plan of experiments for the next round. Such a strategy is in accordance with previously published automated HT platforms for bioprocess development [18,19]. Further extension of such an automated flow can be envisioned by a full closed-loop system as recently published by Wu and Zhou [18].…”
Section: Discussionsupporting
confidence: 71%
“…However, human involvement was still needed in most steps, for example, in designing the experimental plan, in programming and initiating the liquid handling unit, in data treatment obtained from the plate reader, as well as in modification the plan of experiments for the next round. Such a strategy is in accordance with previously published automated HT platforms for bioprocess development [18,19]. Further extension of such an automated flow can be envisioned by a full closed-loop system as recently published by Wu and Zhou [18].…”
Section: Discussionsupporting
confidence: 71%
“…The Highland Games competition draws upon a rich tradition of collaboration and benchmarking in the precompetitive advancement of industries, including the elucidation of CHO cell metabolism (Hefzi et al, 2016), the benchmarking of MHC Class II binding prediction methods (Andreatta et al, 2018), the characterization of the NISTmAb (Schiel & Turner, 2018), the A‐Mab QBD exercise (CMC Biotech Working Group, 2009), high‐throughput process development Olympiad 2014 (http://www.htpdmeetings.com; Welsh et al, 2016) the Industrial Fluid Properties Simulation Challenge (http://fluidproperties.org/), the long‐running CASP protein competitions of the Protein Structure Prediction Center (http://predictioncenter.org/casp13) and (in a different but increasingly relevant field) the Kaggle competition (http://www.kaggle.com) for development of data science tools. In all these diverse areas, competition and benchmarking have advanced the state‐of‐the‐art, especially when competitors generously share knowledge of best practices.…”
Section: Discussionmentioning
confidence: 99%
“…Separations with three or more similar compounds in the feed are often complex and therefore typically require considerably more optimization than the initial mAb capture step. Examples of such process development efforts to achieve sufficient clearance from antibody aggregates are reported in the literature [1][2][3][4][5] ; examples of ternary separations involving aggregates as well as other product-related impurities are less frequent. [6][7][8][9] Other examples of ternary mixtures comprising non-mAb proteins, namely BSA, ovalbumin, cytochrome C, and ribonuclease A, are commonly employed to study model-based optimization problems.…”
Section: Introductionmentioning
confidence: 99%